ARNI
Price:
$0.0001
Market Cap:
$4.93K
Arno Therapeutics, Inc., headquartered in Flemington, New Jersey, operates as a biopharmaceutical enterprise focused on discovering and advancing treatments for cancer and other severe health conditions. The company's developmental portfolio includes several key compounds: Onapristone, a type 1 anti-progestin hormone blocker, is currently undergoing Phase I/II clinical trials. This therapeutic is being investigated for its efficacy in treating various solid tumors, such as breast and endometrial cancers in post-menopausal women, and advanced castration-resistant prostate cancer in men. AR-12, an orally administered cancer therapy, has successfully completed Phase I clinical studies for solid...[Read more]
Industry
Biotechnology
IPO Date
2008-06-11
Stock Exchange
OTC
Ticker
ARNI
According to Arno Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.07% compared to the average of -1.08 of the last 4 quarters.
The mean historical PE Ratio of Arno Therapeutics, Inc. over the last ten years is 27.94. The current -0.01 PE Ratio has changed -103.58% with respect to the historical average. Over the past ten years (40 quarters), ARNI's PE Ratio was at its highest in in the September 2007 quarter at 82.43. The PE Ratio was at its lowest in in the December 2007 quarter at -360.61.
Average
27.94
Median
-1.73
Minimum
-240.17
Maximum
535.55
Discovering the peaks and valleys of Arno Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 143.99%
Maximum Annual PE Ratio = 535.55
Minimum Annual Increase = -584.02%
Minimum Annual PE Ratio = -240.17
| Year | PE Ratio | Change |
|---|---|---|
| 2015 | -0.61 | -134.89% |
| 2014 | 1.75 | -584.02% |
| 2013 | -0.36 | -58.71% |
| 2012 | -0.88 | -86.14% |
| 2011 | -6.31 | 143.99% |
| 2010 | -2.59 | -12.01% |
| 2009 | -2.94 | -27.07% |
| 2008 | -4.03 | -100.75% |
| 2007 | 535.55 | -322.99% |
| 2006 | -240.17 | 3.71% |
The current PE Ratio of Arno Therapeutics, Inc. (ARNI) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.26
5-year avg
-1.28
10-year avg
27.94
Arno Therapeutics, Inc.’s PE Ratio is less than Panacos Pharmaceuticals, Inc. (-0.00), less than Calithera Biosciences, Inc. (-0.00), less than TetraLogic Pharmaceuticals Corporation (-0.00), less than Innovation1 Biotech Inc. (-0.00), less than Better Therapeutics, Inc. (-0.00), greater than Oncology Pharma Inc. (-861.18), less than Baudax Bio, Inc. (-0.00), less than Kaleido Biosciences, Inc. (-0.00), greater than Ampio Pharmaceuticals, Inc. (-0.02), less than Tengion, Inc. (-0.00),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.00 | $5.37K | |
| -0.00 | $1.46K | |
| -0.00 | $979.00 | |
| -0.00 | $4.49K | |
| -0.00 | $5.45K | |
| -861.18 | $1.67M | |
| -0.00 | $4.36K | |
| -0.00 | $4.26K | |
| -0.02 | $207.88K | |
| -0.00 | $4.03K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arno Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arno Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arno Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Arno Therapeutics, Inc. (ARNI)?
What is the highest PE Ratio for Arno Therapeutics, Inc. (ARNI)?
What is the 3-year average PE Ratio for Arno Therapeutics, Inc. (ARNI)?
What is the 5-year average PE Ratio for Arno Therapeutics, Inc. (ARNI)?
How does the current PE Ratio for Arno Therapeutics, Inc. (ARNI) compare to its historical average?